Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function

Multipotent mesenchymal stromal cells (MSCs) have emerged as a promising therapy for autoimmune diseases, including multiple sclerosis (MS). Administration of MSCs to MS patients has proven safe with signs of immunomodulation but their therapeutic efficacy remains low. The aim of the current study h...

Full description

Saved in:
Bibliographic Details
Main Authors: Per Anderson, Elena Gonzalez-Rey, Francisco O’Valle, Francisco Martin, F. Javier Oliver, Mario Delgado
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2017/2389753
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562028442550272
author Per Anderson
Elena Gonzalez-Rey
Francisco O’Valle
Francisco Martin
F. Javier Oliver
Mario Delgado
author_facet Per Anderson
Elena Gonzalez-Rey
Francisco O’Valle
Francisco Martin
F. Javier Oliver
Mario Delgado
author_sort Per Anderson
collection DOAJ
description Multipotent mesenchymal stromal cells (MSCs) have emerged as a promising therapy for autoimmune diseases, including multiple sclerosis (MS). Administration of MSCs to MS patients has proven safe with signs of immunomodulation but their therapeutic efficacy remains low. The aim of the current study has been to further characterize the immunomodulatory mechanisms of adipose tissue-derived MSCs (ASCs) in vitro and in vivo using the EAE model of chronic brain inflammation in mice. We found that murine ASCs (mASCs) suppress T cell proliferation in vitro via inducible nitric oxide synthase (iNOS) and cyclooxygenase- (COX-) 1/2 activities. mASCs also prevented the lipopolysaccharide- (LPS-) induced maturation of dendritic cells (DCs) in vitro. The addition of the COX-1/2 inhibitor indomethacin, but not the iNOS inhibitor L-NAME, reversed the block in DC maturation implicating prostaglandin (PG) E2 in this process. In vivo, early administration of murine and human ASCs (hASCs) ameliorated myelin oligodendrocyte protein- (MOG35-55-) induced EAE in C57Bl/6 mice. Mechanistic studies showed that mASCs suppressed the function of autoantigen-specific T cells and also decreased the frequency of activated (CD11c+CD40high and CD11c+TNF-α+) DCs in draining lymph nodes (DLNs). In summary, these data suggest that mASCs reduce EAE severity, in part, through the impairment of DC and T cell function.
format Article
id doaj-art-0c28c6cba7c74cdcac226244069c78e3
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-0c28c6cba7c74cdcac226244069c78e32025-02-03T01:23:31ZengWileyStem Cells International1687-966X1687-96782017-01-01201710.1155/2017/23897532389753Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell FunctionPer Anderson0Elena Gonzalez-Rey1Francisco O’Valle2Francisco Martin3F. Javier Oliver4Mario Delgado5Institute of Parasitology and Biomedicine “López-Neyra”, CSIC, PTS, Granada, SpainInstitute of Parasitology and Biomedicine “López-Neyra”, CSIC, PTS, Granada, SpainSchool of Medicine, Department of Pathology, IBIMER, CIBM, University of Granada, Granada, SpainGENYO, Centre of Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, SpainInstitute of Parasitology and Biomedicine “López-Neyra”, CSIC, PTS, Granada, SpainInstitute of Parasitology and Biomedicine “López-Neyra”, CSIC, PTS, Granada, SpainMultipotent mesenchymal stromal cells (MSCs) have emerged as a promising therapy for autoimmune diseases, including multiple sclerosis (MS). Administration of MSCs to MS patients has proven safe with signs of immunomodulation but their therapeutic efficacy remains low. The aim of the current study has been to further characterize the immunomodulatory mechanisms of adipose tissue-derived MSCs (ASCs) in vitro and in vivo using the EAE model of chronic brain inflammation in mice. We found that murine ASCs (mASCs) suppress T cell proliferation in vitro via inducible nitric oxide synthase (iNOS) and cyclooxygenase- (COX-) 1/2 activities. mASCs also prevented the lipopolysaccharide- (LPS-) induced maturation of dendritic cells (DCs) in vitro. The addition of the COX-1/2 inhibitor indomethacin, but not the iNOS inhibitor L-NAME, reversed the block in DC maturation implicating prostaglandin (PG) E2 in this process. In vivo, early administration of murine and human ASCs (hASCs) ameliorated myelin oligodendrocyte protein- (MOG35-55-) induced EAE in C57Bl/6 mice. Mechanistic studies showed that mASCs suppressed the function of autoantigen-specific T cells and also decreased the frequency of activated (CD11c+CD40high and CD11c+TNF-α+) DCs in draining lymph nodes (DLNs). In summary, these data suggest that mASCs reduce EAE severity, in part, through the impairment of DC and T cell function.http://dx.doi.org/10.1155/2017/2389753
spellingShingle Per Anderson
Elena Gonzalez-Rey
Francisco O’Valle
Francisco Martin
F. Javier Oliver
Mario Delgado
Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function
Stem Cells International
title Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function
title_full Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function
title_fullStr Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function
title_full_unstemmed Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function
title_short Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function
title_sort allogeneic adipose derived mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by regulating self reactive t cell responses and dendritic cell function
url http://dx.doi.org/10.1155/2017/2389753
work_keys_str_mv AT peranderson allogeneicadiposederivedmesenchymalstromalcellsameliorateexperimentalautoimmuneencephalomyelitisbyregulatingselfreactivetcellresponsesanddendriticcellfunction
AT elenagonzalezrey allogeneicadiposederivedmesenchymalstromalcellsameliorateexperimentalautoimmuneencephalomyelitisbyregulatingselfreactivetcellresponsesanddendriticcellfunction
AT franciscoovalle allogeneicadiposederivedmesenchymalstromalcellsameliorateexperimentalautoimmuneencephalomyelitisbyregulatingselfreactivetcellresponsesanddendriticcellfunction
AT franciscomartin allogeneicadiposederivedmesenchymalstromalcellsameliorateexperimentalautoimmuneencephalomyelitisbyregulatingselfreactivetcellresponsesanddendriticcellfunction
AT fjavieroliver allogeneicadiposederivedmesenchymalstromalcellsameliorateexperimentalautoimmuneencephalomyelitisbyregulatingselfreactivetcellresponsesanddendriticcellfunction
AT mariodelgado allogeneicadiposederivedmesenchymalstromalcellsameliorateexperimentalautoimmuneencephalomyelitisbyregulatingselfreactivetcellresponsesanddendriticcellfunction